ABSTRACT: The osteoclast is the primary bone resorbing cell. It is a highly specialized multinucleated cell whose primary function is to help in the control of calcium homeostasis. The osteoclast has been very difficult to study because of its relative inaccessability, low numbers, and fragility when isolated from bone. Recently, techniques have been developed to study the cell biology of the osteoclast that have expanded our ability to understand the biological and functional properties of osteoclasts. In this article, studies on the origin of the osteoclast are reviewed and the differentiation markers that are used to detect cells in the osteoclast lineage are discussed. Factors that affect osteoclast differentiation are presented and model systems currently in use for studying osteoclast differentiation are evaluated for their relative strengths and weaknesses. In addition, osteoclast differentiation during tooth eruption and root resorption and the effects of bone matrix elements on osteoclast differentation are reviewed.
INTRODUCTION
The osteoclast is the primary bone-resorbing cell. It is a highly specialized multinucleated cell whose primary function is to help in the control of calcium homeostasis. The osteoclast is an extremely large cell, ranging in size from 50 up to 100 ,um in diameter. It is multinucleated and may contain between 2 and 100 nuclei per cell, but usually contains between 10 and 20. The osteoclast is located on endosteal bone surfaces, within the Haversian system, and on periosteal surfaces beneath the periosteum. Osteoclasts are seen infrequently in normal adult bone. Osteoclasts are most abundant at sites of active bone cell activity, such as metaphyses of growing bone.
Osteoclasts have several unique ultrastructural features. The characteristic ruffled border that forms at the site where the osteoclast is attached to bone matrix is a convolution of plasma membrane with many long cytoplasmic processes. The plasma membrane is closely apposed to the bone surface with an adjacent organellefree area, the clear zone, which is rich in actinlike filaments.' Other ultrastructural characteristics of osteoclasts include large numbers of lysosomes, numerous pleomorphic mitochondria, and extensive Golgi complexes located around the nucleus. The cytoplasm is characterized by dense granules. In addition to the cytoplasmic dense granules, osteoclasts have many prominent vesicles, especially in the region of the ruffled border.2 The multiple nuclei are centrally located, but have a highly variable shape and contain one prominent nucleolus per nucleus. Thus, the osteoclast is a highly specialized cell with unique ultrastructural features that help to identify and differentiate it from other multinucleated cells present in the bone marrow cavity.
II. ORIGIN OF THE OSTEOCLAST
The osteoclast has been very difficult to study because of its relative inaccessibility, low numbers, and fragility when isolated from bone.
Recently, techniques have been developed to study the cell biology of the osteoclast, and these techniques have expanded our ability to understand the biological and functional properties of osteoclasts. These techniques have allowed rapid progress to be made toward the understanding of the origin of the osteoclast and the factors that affect its differentiation.
The origin of the osteoclast has been and continues to be a subject of intense investigation and controversy. A variety of studies have clearly indicated that the osteoclast is hematopoietic in origin and not bone derived. Walker et al. 34 showed that parabiotic linkage of an osteopetrotic mouse with a normal littermate cured the osteopetrosis and induced the formation of a marrow cavity in these osteopetrotic animals. Gothlin and Ericsson5 showed that when one of a pair of parabiotic rats is lethally irradiated and the cells of the nonirradiated animal are labeled with tritiated thymidine or thorotrast,6 osteoclasts formed in the irradiated animal were derived from the nonirradiated animal. Similarly, studies using quailchick chimeras,7 in which quail bone rudiments are grafted onto chick allantoic membranes, have shown that the osteoclasts that formed are predominantly host in origin. This system takes advantage of the distinctive nuclear morphology of quail and chick cells, and permits identification of host and donor cells. Jotereau and LeDouarin8 have confirmed that the osteoclasts formed in quail-chick chimeras are not bone derived.
Transplantation of hematopoietic tissue into lethally irradiated rodents or humans has shown that the osteoclast precursor is present in hematopoietic tissues. Walker et al. 9 reported that transplantation of spleen and marrow cells into osteotropic mice results in removal of the excess bone present in these animals. Marks'0 has shown that transplantation of spleen cells into the osteopetrotic ia rat can cure the disease. In contrast to untreated ia rats whose osteoclasts lack ruffled borders, infusion of mononuclear spleen cells" resulted in the formation of osteoclasts with ruffled borders. Further, the transplantation studies of Coccia and co-workers'2 at the University of Minnesota and subsequent studies by others '3 have shown that bone marrow transplantation may cure some patients with osteopetrosis. The donor origin of the osteoclasts was confirmed in these studies, because female patients were transplanted with marrow from their HLA-matched male siblings. Karyotypic analysis of the osteoclasts formed in these patients revealed that these cells were donor in origin. Transplantation of osteopetrotic rodents with liver cells and peripheral blood mononuclear cells, as well as cell suspensions containing hematopoietic stem cells,' 114, 15 also indicated that osteopetrosis can be cured by transplantation of hematopoietic tissue. All these studies are consistent with the hypothesis that the osteoclast precursor is a mononuclear cell that is hematopoietic in origin.
The osteoclast forms by fusion of mononuclear precursors. The studies of Kahn and Simmons7 using quail-chick chimeras showed that some osteoclasts contained both quail-and chicktype nuclei. Similarly, Baron and Vignery'6 reported that the number of osteoclasts increased prior to the number of nuclei per cell in animals treated with PTH. Feldman and co-workers '7 found no evidence of cell division when osteoclast numbers were increased in animals given PTH. These data further suggest that the osteoclasts are derived by cell fusion rather than endomitosis. Young'8 showed that when cells were exposed to tritiated thymidine to label dividing cells, osteoclasts were formed by fusion of mononuclear precursors rather than mitotic division. Taken together, these data support the concept that multinucleated osteoclasts are formed by fusion of mononuclear precursors that are hematopoietic in origin, rather than bone derived, and that these osteoclast precursors pass through the circulation.
However, there is still dispute about the specific cell lineage that gives rise to the osteoclast.
Ries and Gong'9 described mononuclear osteoclast precursors in periosteal bone. These cells had a ruffled border and contained acid phosphatase. Baron and co-workers20 have also described the microscopic characteristics of cells that were believed to be osteoclast precursors. The cells had a low nuclear-to-cytoplasmic ratio; an abundance of ribosomes, both attached to the endoplasmic reticulum and free in the cytoplasm; polysomes with a characteristic rosette organization; multiple Golgi complexes; abundant mitochondria; and numerous cytoplasmic extensions. When these mononuclear precursors were attached to the bone surface, the plasma membranes of the adherent precursor cells were closely associated with the calcified bone surface. Coated pits or coated patches, mostly circumscribing small calcified spicules, were frequently demonstrated on the cytoplasmic processes that were attached to the bone. The cells contained tartrateresistant acid phosphatase and nonspecific esterase, suggesting they were monocytic in origin.
As noted above, the monocyte-macrophage lineage is the leading candidate for the osteoclast lineage. A number of studies first performed in vivo, and more recently in vitro, suggested that osteoclasts were derived from cells of the mononuclear phagocyte system. However, positive identification of osteoclast precursors has yet not been demonstrated conclusively. Baron and coworkers20 developed a model system in the rat in which it was possible to induce the formation of multinucleated osteoclasts in a predictable manner. These workers showed in vivo that, prior to formation of multinucleated osteoclasts, mononuclear cells containing nonspecific esterase appear prior to mononuclear cells containing tartrate-resistant acid phosphatase. Both enzymes were present in a number of cells, suggesting that these were steps in the differentiation of a single cell population. The mature osteoclast precursor also contained nonspecific esterase, which was lost with further differentiation. The mature multinucleated osteoclasts contained only tartrate-resistant acid phosphatase. These in vivo data suggested that members of the monocyte-macrophage lineage are mononuclear precursors for the osteoclast.
The classic experiments of Fishman and Hay2' in regenerating newt limb demonstrated that osteoclasts were formed by the fusion of labeled leukocytes that were probably monocytes histologically. Jee and Noland22 showed that osteoclasts contained charcoal particles after surrounding macrophages had incorporated these particles. Tinkler et al.23 injected tritiated thymidine labeled peripheral blood murine monocytes into syngeneic recipients treated with 1,25-dihydroxyvitamin D3 and showed that the osteoclasts that formed contained the labeled nuclei. Similarly, Zambonin-Zallone et al.24 found that some peripheral blood monocytes could fuse with purified chicken osteoclasts in vitro. More recently Burger and co-workers25 reported that mouse marrow cells stimulated with a source of colony stimulating factor, and then cultured with fetal bone rudiments devoid of osteoclasts, formed osteoclasts in vitro. They identified the osteoclast precursor as an immature monocyte by histological studies.
Ousler and co-workers26 also reported that monoclonal antibodies that identify macrophages and macrophage polykaryons also cross-reacted with osteoclasts. Similarly, Athanasou et al. 27 have shown that macrophage antigens are expressed on the osteoclasts. This work is in contrast to that of Horton and co-workers,28 who failed to find monocyte-specific antigens expressed on osteoclasts.
Most recently, Kurihara and co-workers29 have shown, using human bone marrow culture systems, that osteoclast-like multinucleated cells are formed from highly purified populations of CFU-GM. In addition, Schneider and coworkers30 have shown in murine systems that fractions enriched for CFU-GM give rise to osteoclasts. These data suggest that the osteoclast precursors are derived from the mononuclear phagocyte lineage because cells that contain both monocytic markers and osteoclastic markers are present prior to the formation of osteoclasts, and that precursors for monocyte-macrophages also give rise to osteoclasts. However, other workers have argued that the osteoclast is derived from a unique lineage that is a distinct branch from the monocyte-macrophage lineage. Chambers Gay and co-workers50 have examined carbonic anhydrase activity in chicken osteoclasts by electron microscopy. Using histochemical techniques, positive staining reactions were seen in the cytosol, the Golgi apparatus, and other vesicles and on the plasma membrane, ruffled border, and the bone surface beneath the osteoclast. The carbonic anhydrase was bound to the plasma membrane of the ruffled border. These workers have suggested that carbonic anhydrase may be released into the resorbing bone along with lysosomal hydrolases. This enzyme appears to play a key role in the bone resorptive process.
Baron and co-workers5' recently reported that the chicken osteoclast has a highly specific concentration of a sodium potassium ATPase in the plasma membrane. However, Gluck and coworkers52 demonstrated that it is a vacuolar proton pump that has enhanced expression in the chicken osteoclast and that the vacuolar proton pump is polarized to the resorptive surface during osteoclastic bone resorption. Enhanced expression of the vacuolar proton pump appeared to be a good marker for osteoclast differentiation. However, none of the studies reported above has demonstrated when during osteoclast differentiation these enzymatic activities are first expressed.
Calcitonin Osteoclast-like cells have also been isolated by enzymatic digestion of rodent calvaria.69-72 These cells have osteoclast characteristics, including appropriate calcitonin responses and high acid-phosphatase activities. However, the majority of these cells are mononuclear or binuclear, and lack the characteristic morphologic appearance of osteoclasts. Organ cultures using fetalrat long bones have also been used extensively to examine osteoclast activity.73 These techniques are excellent for obtaining osteoclasts for morphologic studies and to study bone resorption on calcified surfaces. Organ culture systems do not allow studies of the differentiation of osteoclasts from their precursors or yield sufficient numbers of osteoclasts for biochemical studies.
To overcome these problems, other model systems have been used to study osteoclast differentiation. Rodent peritoneal marcrophages and human monocytic cell lines74-76 have been used as model systems for osteoclasts. Macrophages can release 45Ca from bone fragments, and the release of calcium is increased when the cells fuse and become multinucleated. 77 Similarly, HL60 cells, a human promyelocyte cell line, when 78 Osteoclasts in alveolar bone respond to PTH and calcitonin, and have enzymatic properties similar to osteoclasts isolated from long bones. In this system bone remodeling is induced by extracting molars from adult rats. The absence of antagonist teeth induces bone remodeling along the periosteum of the mandible. The animals are sacrificed every 24 h, and the alveolar bone is processed for light microscopy, ultrastructural studies, and cytochemical studies. Using this system, Baron et al. 20 have shown that mononuclear cells that contain nonspecific esterase, a marker of monocyte macrophages, are present prior to formation of osteoclasts. Subsequently cells that contain both nonspecific esterase and tartrate-resistant acid phosphatase, a marker enzyme of osteoclasts, appear at the future site of osteoclast formation. Finally, tartrateresistant acid phosphatase positive mononuclear cells lacking nonspecific esterase form multinucleated osteoclasts. However, osteoclast precursor cells cannot be easily isolated from these bones, and histologic specimens must be prepared in order to do these studies.
In an attempt to overcome some of the problems of low osteoclast precursor numbers obtainable from the systems noted above, bone marrow culture systems have been developed in which cells with the osteoclast phenotype form. Since the osteoclast is hematopoietic in origin, it is reasonable that bone marrow culture systems should be useful for studying osteoclast differentiation. Several marrow culture systems have been developed to examine osteoclast-like cell formation in vitro. Burger We have used these human marrow culture systems to examine the mechanisms of action of a variety of growth factors on osteoclast-like cell formation in vitro and have more recently used these culture systems to identify precursors for these osteoclast-like multinucleated cells.29 '89 Precursors for these cells were isolated by culturing bone marrow mononuclear cells in semisolid media in the presence of CSF-GM or IL-3 for 1 week. The CFU-GM colonies that formed were then treated in situ with 1,25D3, and four types of colonies developed. These types of colonies include colonies composed of polygonal shaped cells, macrophage colonies, granulocytic colonies, and colonies of mixed hematopoietic lineages.
The polygonal cells were the committed precursors for the osteoclast-like multinucleated cells. These precursors cross-reacted strongly with the 23c6 monoclonal antibody,29 expressed calcitonin receptors,57 and showed enhanced expression of the vacuolar proton pump. 57 Similarly, Nijweide and co-workers42 have used FDCP-C2GM cells, another multipotent hematopoietic murine cell line, and demonstrated that when these cells are cocultured with a fetal bone rudiment, osteoclast-like cells formed. Yoneda and co-workers93 have recently reported that HL60 cells, a human promyelocytic cell line, cultured in methylcellulose and treated with conditioned media from the MH85 tumor cell line, a human squamous cell tumor that induces hypercalcemia, followed by 1,25D3, form multinucleated cells that expressed an osteoclast phenotype. These multinucleated cells reacted strongly with the 23c6 monoclonal antibody, formed resorption lacunae on calcified matrices, and resorbed bone, and the bone resorption could be inhibited by calcitonin. Thus, there are now a variety of model systems available for examining osteoclast precursor cell differentiation that can be used both to identify the precursor(s) and to examine the mechanism of action of osteotropic factors. For example, one can determine if an osteotropic factor acts only on the less-differentiated osteoclast precursor or only on the committed osteoclast precursor, and if it stimulates proliferation or differentiation and fusion of these cells, etc. Further, one can determine if the factors only act on the differentiated multinucleated cell, rather than on the precursors. Table 2 lists the currently used model systems for studying osteoclast differentiation. 113 have reported recently that GM-CSF can related peptide that is produced by tumor cells stimulate the proliferation of murine osteoclast and induces hypercalcemia'09,l'0 also increased precursors when the cultures are treated sequenosteoclast-like multinucleated cell formation in tially with GM-CSF followed by 1,25D3. Howmurine mouse cultures."' ever, when bone marrow cultures are treated simultaneously with GM-CSF and 1,25D3, there is inhibition of osteoclast-like cell formation in C. GM-CSF murine long-term marrow cultures.
V. FACTORS AFFECTING OSTEOCLAST DIFFERENTIATION
Lorenzo and co-workers"14 have reported that Granulocyte macrophage colony stimulating GM-CSF had little effect on osteoclasts in murine factor (GM-CSF), a hematopoietin that can affect organ cultures in terms of bone resorptive activity several hemopoietic lineages, has been reported but significantly decreased the percentage of reto have both stimulatory and inhibitory effects cently replicated osteoclast progenitor cell nuclei on osteoclasts and osteoclast differentiation. present in the osteoclasts in bones treated with
MacDonald and co-workers'"2 have shown that parathyroid hormone. GM-CSF did increase the treatment of long-term marrow cultures for the number of myeloid cells in the marrow space of first week with GM-CSF, followed sequentially the organ cultures. They concluded that GM-CSF by treating the cultures the last 2 weeks with regulates the development of osteoclasts from re-1 ,25D3, induces a remarked increased in osteocenfly replicated precursors by forcing cells away clast-like multinucleated cell formation. Further, from the osteoclast lineage. Thus, the role of Kurihara et al. 29 have shown that GM-CSF stim-GM-CSF in osteoclast formation and differentiaulates proliferation of the less differentiated pretion is still unclear.
D. CSF-1 CSF-1 or marcrophage colony stimulating factor can stimulate the growth of osteoclast precursor cells. MacDonald et al."12 reported that CSF-1 modestly increased osteoclast-like cell formation in long-term human marrow cultures when the cells were treated sequentially with CSF-1 followed by 1,25D3. Takahashi and coworkers"3 reported that CSF-1 was the most potent stimulator of murine osteoclast precursor growth when bone marrow cells were grown initially in semisolid media with CSF-I and then cocultured over ST2 cells in the presence of 1,25D3 and dexamethasone. However, when CSF-1 was added simultaneously with 1,25D3 to the coculture system, CSF-1 inhibited osteoclast-like multinucleated cell formation. Further, Wijngaert and co-workers" 5 have shown that CSF-I inhibited the growth of osteoclast precursor cells from whole-mouse bone marrow. Thus, depending on the culture system that is used and the time of addition, CSF-I can either stimulate or inhibit osteoclast-like cell formation.
E. Interleukin-3
Interleukin-3 (IL-3) or multipotent CSF is a T cell product that stimulates the growth of primitive hematopoietic progenitors, as well as erythroid burst-forming cells and basophil precursors. Kurihara and co-workers'"6 have shown that IL-3 can stimulate the growth of precursors for osteoclast-like cells formed in murine marrow cultures. Similarly, Hattersley et al."7 reported that IL-3 can stimulate the growth of murine pluripotent stem cells, which in turn can differentiate to calcitonin receptor positive cells that do not resorb bone. Kurihara et al. 29 have shown, using human marrow precursor cultures, that IL-3 can increase precursors for osteoclasts, provided that these cells are then sequentially cultured in the presence of 1,25D3. Barton and co-workers"8 have recently reported that IL-3 can also increase multinucleated cell formation in long-term murine marrow cultures. The multinucleated cells expressed tartrate-resistant acid phosphatase activity and appeared to be osteoclasts. Takahashi and co-workers' 3 have also reported that IL-3 can stimulate the growth of murine hematopoietic precursors that give rise to osteoclasts. However, when IL-3 was added simultaneously with 1,25D3 to these cultures, it also inhibited osteoclast-like cell formation in long-term murine marrow cultures. Thus, the overall effects of hematopoietic growth factors appear to stimulate the growth of the osteoclast precursors and to induce their differentiation toward other lineages, unless they are cultured sequentially in the presence of 1,25D3. It appears that 1,25D3 cannot compete equally with the hematopoietic growth factors for the differentiation of the common precursor for the osteoclast and the monocyte-macrophage. These cells must be treated initially with the growth factor to expand the less-differentiated precursor pool and then with 1,25D3 by itself to induce further differentiation of the precursors toward the osteoclast lineage.
F. Transforming Growth Factor-a and -I
Transforming growth factor-a (TGF-cx) is a polypeptide of 5700 Da that is produced by tumor cells and is partially homologous with epidermal growth factor. TGF-a enhances osteoclastic bone resorption,'19120 and Takahashi and co-workers'2' have shown that TGF-a can also stimulate the formation of osteoclast-like multinucleated cells in long-term human marrow cultures. TGF-a appears to stimulate the growth of the precursors for these cells, but requires the presence of 1,25D3 to complete the differentiation process. Thus, TGF-a only stimulates osteoclast-like cell formation when the cells are treated sequentially with TGF-a followed by 1 ,25D3. TGF-a by itself has no colony-stimulating factor activity, so that it appears to be acting on a different cell than the cell that is the target for hemopoietic growth factors, such as GM-CSF.
Unlike TGF-a, TGF-13, which is produced by a number of normal tissues, including bone, inhibits osteoclast-like cell formation'22 but will stimulate osteoclastic bone resorption in neonatal mouse calvaria."'9 This is due to the fact that TGF-P induces prostaglandin synthesis and prostaglandins are potent stimulators of bone resorption in the neonatal mouse calvaria assay. In contrast, in systems where prostaglandins are not as important, TGF-P is a potent inhibitor of osteoclast formation. TGF-P inhibits osteoclast-like cell formation in two ways, by blocking fusion of the precursors and by shifting precursors toward the granulocytic lineage. '22 G. Interleukin-1
Interleukin-la and -I,1 are potent stimulators of bone resorption. Gowen and co-workers ' and Suda and co-workers'" have reported that IL-6 can enhance osteoclastic bone resorption in a mouse calvarial resorption assay. Recendly, Kurihara and co-workers'31 have shown that IL-6 stimulates the formation of osteoclast-like multinucleated cells in long-term human marrow cultures and increases the percentage of those cells reacting with the 23c6 monoclonal antibody. IL-6 in this culture system induces IL-I production, which in turn increases osteoclast-like cell formation. IL-6 appears to stimulate the growth and differentiation of precursors for these osteoclastlike cells.
J. Gamma Interferon
Gamma interferon is a potent inhibitor of IL-1-stimulated bone resorption in organ cultures. 132 In addition, Takahashi and co-workers '33 have shown that gamma interferon inhibits the formation of osteoclast-like multinucleated cells in long-term human marrow cultures. Gamma interferon appears to act by inhibiting the proliferation of the precursors, as well as inhibiting fusion of their differentiated progeny to form multinucleated cells. This culture system is exquisitely sensitive to gamma interferon and is inhibited by concentrations of gamma interferon as low as 4 U/ml. Interferon-a can also inhibit the formation of osteoclast-like multinucleated cells by a similar mechanism of action. 34 
K. Calcitonin
Calcitonin inhibits osteoclastic bone resorption in murine organ cultures '35`36 '54 showed that transplantation of these osteopetrotic ia rats with normal rat spleen cells induced bone resorption and tooth eruption. Wise and coworkers'55 and Marks et al. ' 56 have shown that tartrate-resistant, acid phosphate-positive mononuclear cells invade the dental follicle prior to the onset of eruption. The dental follicle is a sac of loose connective tissue required for tooth eruption.'57 These tartrate-resistant, acid phosphatase-positive mononuclear cells then formed osteoclasts. Osteoclasts were present in large numbers on the surface of the bony crypt surrounding the teeth and then declined in number as the tooth erupted. The origin of these osteoclast precursors is unclear. It is possible they are derived from resting precursors present in the alveolar bone or from blood-borne precursors. Either way it is clear that there is fusion of these mononuclear precursors to form osteoclasts, termed ondotoclasts, in teeth.
Similarly, during root resorption of deciduous teeth, odontoclasts also play a role. In the active phase of root resorption, many odontoclasts with well-developed ruffled borders and clear zones are present at the site of resorption. The odontoclasts are essential for removing both the hard and soft tissue during the shedding of the deciduous teeth.
Pierce'58 has suggested that the osteoclasts phagocytose bone and mineral, in addition to dissolving the bone in situations associated with rapid bone turnover, such as tooth eruption. It has been proposed that osteoblasts present in the resorptive organ remove the osteoid layer and induce osteoclastic bone resorption by permitting the osteoclasts to come in contact with the bone min-eral, stimulating bone resorption. 1 '6 In teeth the osteoblast may provide the collagenase activity needed for removal of matrix components needed to stimulate osteoclast activity. The mechanisms responsible for recruitment of osteoclast precursors to the site of tooth eruption have not been clearly defined, but matrix elements may play a role in osteoclast precursor differentiation.
Vil. SUMMARY
Taken together these data demonstrate the osteoclast precursor is hematopoietic in origin and most likely is derived from cells in the monocyte-macrophage lineage. The branch points along the differentiation pathway of the monocyte-macrophage lineage that can give rise to the osteoclast appear to be multiple, with both lessdifferentiated and more-differentiated members of this lineage forming osteoclasts. Further studies will have to be done to confirm the differentiation pathway for the osteoclast, as well as to identify specific differentiation markers that may be unique to osteoclasts. Using model systems for osteoclast formation, the mechanisms of action for the effects of osteotropic factors and cytokines on osteoclast formation can now be determined. In the future these model systems may be useful for developing osteoclast precursor cell lines that may allow the production of sufficient numbers of osteoclasts and osteoclast precursors for molecular biological and biochemical characterization. The use of the polymerase chain reaction to do RNA phenotyping of osteoclast precursors may further reveal some of the molecular events that occur during osteoclast differentiation. Bone matrix elements and osteoblasts appear to play an important role in osteoclast differentiation. Future studies will continue to expand our understanding of the important interactions between bone cells, bone, and the osteoclast.
